Suvoda puts the clinical trial AI assistant Sofia into use

- Suvoda has put the clinical trial AI assistant Sofia into use to accelerate the process of obtaining answers and taking action.

Key Points

• Clinical trials require AI with safety and control mechanisms. Such AI must be specifically designed for regulated industries, as these industries have a significant impact on individuals and require the retention of audit records.
• Sofia helps experimental teams to more conveniently obtain complex and dynamically changing experimental data, and these teams usually have to handle a large amount of work with strict time limits.
• The testing team can obtain answers more quickly and make decisions with greater confidence. Sofia is not just about simply retrieving information; it can also represent users with heavier workloads to perform authorized operations within the system, all while adhering to the permissions and audit records required for clinical trials.

Conshohocken, Pennsylvania, October 13, 2026 / PRNewswire / -- Clinical trial technology company Suvoda announced today that the AI assistant embedded in the Suvoda platform is now available for all new clinical trials using Suvoda RTSM / IRT or Suvoda eCOA. This Sofia, designed specifically for regulated clinical research, provides sponsors, CRO, and research centers with faster access to trial data and the ability to act upon it accordingly.

“Sofia has taken on the daily operational tasks, allowing sponsors, CRO, and the research center to focus on decisions that require their judgment,” said Suvoda, the Chief Product Officer of E.K. “We developed it to the rigorous standards required by clinical trials, because there is no room for error in this field.”

Clinical trial teams have to handle a large amount of work with strict time constraints. They are responsible for managing drug inventory, reviewing shipping details, supervising patient visit schedules, and managing the completion of questionnaires at centers around the world. Verifying these data processes can distract attention from patients and decisions that require professional judgment. The design goal of Sofia is to change this situation. Its aim is to make complex and constantly changing trial data more accessible, thereby allowing teams to focus their attention on where human experience is most needed.

Sofia was initially launched to some pioneering enterprises, which helped to further refine the product before its current expansion to all new trials using Suvoda RTSM, IRT, and eCOA.

"As early users, we are impressed by the team's rapid integration of Sofia into our daily work processes," said Dawn Sorenson, the director of the IRT Center of Excellence at Daiichi Sankyo under Otsuka Pharmaceutical. "The platform's ability to consolidate documents and answer operational inquiries makes information more accessible and reduces the time spent switching between systems or generating reports. Tasks that used to require multiple steps can now be completed with a simple conversation, which significantly improves the efficiency of trial operations."

A design approach different from the general AI

Some AI tools apply large language models to certain problems, hoping for accurate results. The development approach of Sofia is different. This conversational AI connects the intent of each question with a verified knowledge base of Suvoda, and domain experts transform operational guidelines into verified capabilities. These capabilities are tested on real experimental data and are placed within a governance framework that ensures blindness in the experiments while also generating the audit records required for clinical trials. Currently, Sofia supports more than 40 topics and is continuously expanding its capabilities.

From information to action

Sofia is not merely used for answering questions. For authorized users, Sofia can perform system operations on their behalf within the same conversation. Before taking any action, Sofia will first summarize what is to be done and request confirmation. Each operation is attributed to the user who initiated the request, is subject to the existing roles and permissions, and is recorded in a complete audit log.

Sofia has recently won an award in the artificial intelligence category of the PM360 Innovation Award, which reflects the pragmatic and innovative approach taken by Suvoda in building Sofia. Early users played a key role in constructing a system that truly suited the needs of the testing team.

Frequently Asked Questions

Question: How does Sofia handle data privacy and security?

Answer: Sofia adopts a zero-data retention policy; it never uses customer data to train public models, and strictly limits each user's access to only the content that they are authorized to view within the Suvoda platform.

Question: What is the difference between Sofia and ordinary chatbots?

Answer: Sofia is a deterministic AI assistant, specifically designed to execute expert instructions created by Suvoda on real-time clinical trial data within a governance framework; with user confirmation, it can also perform authorized system operations on behalf of the user.

Question: What languages does Sofia support?

Answer: Sofia will respond in the language used in the question, providing support for global sponsors, CRO, and research center teams that operate across different time zones and regions.

Media contact:

Robin Abad iaSuvoda Director of External CommunicationsFor more information about Suvoda, please visit its news center.